治疗格雷夫斯眼眶病：我们目前处于什么阶段？ - Suppr

Suppr

超能文献

Treating Graves' orbitopathy: where are we?

作者信息

Tanda Maria Laura, Piantanida Eliana, Bartalena Luigi

出版信息

Endocrine. 2012 Apr;41(2):167-8. doi: 10.1007/s12020-012-9607-1.

DOI:10.1007/s12020-012-9607-1

PMID:22274832

Abstract

摘要

相似文献

Treating Graves' orbitopathy: where are we?

Endocrine. 2012 Apr;41(2):167-8. doi: 10.1007/s12020-012-9607-1.

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Endocrine. 2012 Apr;41(2):248-55. doi: 10.1007/s12020-012-9600-8. Epub 2012 Jan 12.

Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Endocrine. 2012 Apr;41(2):320-6. doi: 10.1007/s12020-011-9559-x. Epub 2011 Nov 16.

A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.

J Clin Endocrinol Metab. 2010 May;95(5):2123-31. doi: 10.1210/jc.2009-2470. Epub 2010 Mar 17.

[Graves' ophthalmopathy].

Internist (Berl). 2010 May;51(5):584, 586-8, 590-2, passim. doi: 10.1007/s00108-009-2497-5.

Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.

Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50. doi: 10.1111/j.1365-2265.2008.03279.x. Epub 2008 Apr 21.

Graves' Disease.

N Engl J Med. 2016 Oct 20;375(16):1552-1565. doi: 10.1056/NEJMra1510030.

[Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].

Zhonghua Er Ke Za Zhi. 2005 Jul;43(7):507-9.

Treating the thyroid in the presence of Graves' ophthalmopathy.

Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):313-24. doi: 10.1016/j.beem.2011.09.005.

Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.

Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):1-6. doi: 10.1055/s-0033-1358484. Epub 2013 Nov 7.

引用本文的文献

Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.

J Endocrinol Invest. 2015 Jul;38(7):769-77. doi: 10.1007/s40618-015-0254-2. Epub 2015 Mar 4.

Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy.

Endocrine. 2015 Feb;48(1):241-7. doi: 10.1007/s12020-014-0283-1. Epub 2014 Jun 1.

本文引用的文献

Dose of intravenous steroids and therapy outcome in Graves' orbitopathy.

J Endocrinol Invest. 2011 Dec;34(11):876-80. doi: 10.1007/BF03346732.

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Endocrine. 2012 Apr;41(2):248-55. doi: 10.1007/s12020-012-9600-8. Epub 2012 Jan 12.

Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Endocrine. 2012 Apr;41(2):320-6. doi: 10.1007/s12020-011-9559-x. Epub 2011 Nov 16.

Selenium and the course of mild Graves' orbitopathy.

N Engl J Med. 2011 May 19;364(20):1920-31. doi: 10.1056/NEJMoa1012985.

The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.

J Clin Endocrinol Metab. 2011 Mar;96(3):592-9. doi: 10.1210/jc.2010-2329. Epub 2010 Dec 29.

Pathogenesis of Graves' orbitopathy: a 2010 update.

J Endocrinol Invest. 2010 Jun;33(6):414-21. doi: 10.1007/BF03346614.

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Clin Endocrinol (Oxf). 2011 Jan;74(1):1-8. doi: 10.1111/j.1365-2265.2010.03806.x.

What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?

Clin Endocrinol (Oxf). 2010 Aug;73(2):149-52. doi: 10.1111/j.1365-2265.2010.03783.x. Epub 2010 Feb 10.

Clinical practice. Graves' ophthalmopathy.

N Engl J Med. 2009 Mar 5;360(10):994-1001. doi: 10.1056/NEJMcp0806317.

Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?

J Endocrinol Invest. 2008 Jun;31(6):578-81. doi: 10.1007/BF03346411.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treating Graves' orbitopathy: where are we?

作者信息

Tanda Maria Laura, Piantanida Eliana, Bartalena Luigi

出版信息

Endocrine. 2012 Apr;41(2):167-8. doi: 10.1007/s12020-012-9607-1.

DOI:10.1007/s12020-012-9607-1

PMID:22274832

Abstract

摘要

相似文献

Treating Graves' orbitopathy: where are we?

Endocrine. 2012 Apr;41(2):167-8. doi: 10.1007/s12020-012-9607-1.

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Endocrine. 2012 Apr;41(2):248-55. doi: 10.1007/s12020-012-9600-8. Epub 2012 Jan 12.

Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Endocrine. 2012 Apr;41(2):320-6. doi: 10.1007/s12020-011-9559-x. Epub 2011 Nov 16.

A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.

J Clin Endocrinol Metab. 2010 May;95(5):2123-31. doi: 10.1210/jc.2009-2470. Epub 2010 Mar 17.

[Graves' ophthalmopathy].

Internist (Berl). 2010 May;51(5):584, 586-8, 590-2, passim. doi: 10.1007/s00108-009-2497-5.

Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.

Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50. doi: 10.1111/j.1365-2265.2008.03279.x. Epub 2008 Apr 21.

Graves' Disease.

N Engl J Med. 2016 Oct 20;375(16):1552-1565. doi: 10.1056/NEJMra1510030.

[Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].

Zhonghua Er Ke Za Zhi. 2005 Jul;43(7):507-9.

Treating the thyroid in the presence of Graves' ophthalmopathy.

Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):313-24. doi: 10.1016/j.beem.2011.09.005.

Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.

Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):1-6. doi: 10.1055/s-0033-1358484. Epub 2013 Nov 7.

引用本文的文献

Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.

J Endocrinol Invest. 2015 Jul;38(7):769-77. doi: 10.1007/s40618-015-0254-2. Epub 2015 Mar 4.

Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy.

Endocrine. 2015 Feb;48(1):241-7. doi: 10.1007/s12020-014-0283-1. Epub 2014 Jun 1.

本文引用的文献

Dose of intravenous steroids and therapy outcome in Graves' orbitopathy.

J Endocrinol Invest. 2011 Dec;34(11):876-80. doi: 10.1007/BF03346732.

Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Endocrine. 2012 Apr;41(2):248-55. doi: 10.1007/s12020-012-9600-8. Epub 2012 Jan 12.

Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Endocrine. 2012 Apr;41(2):320-6. doi: 10.1007/s12020-011-9559-x. Epub 2011 Nov 16.

Selenium and the course of mild Graves' orbitopathy.

N Engl J Med. 2011 May 19;364(20):1920-31. doi: 10.1056/NEJMoa1012985.

The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.

J Clin Endocrinol Metab. 2011 Mar;96(3):592-9. doi: 10.1210/jc.2010-2329. Epub 2010 Dec 29.

Pathogenesis of Graves' orbitopathy: a 2010 update.

J Endocrinol Invest. 2010 Jun;33(6):414-21. doi: 10.1007/BF03346614.

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Clin Endocrinol (Oxf). 2011 Jan;74(1):1-8. doi: 10.1111/j.1365-2265.2010.03806.x.

What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?

Clin Endocrinol (Oxf). 2010 Aug;73(2):149-52. doi: 10.1111/j.1365-2265.2010.03783.x. Epub 2010 Feb 10.

Clinical practice. Graves' ophthalmopathy.

N Engl J Med. 2009 Mar 5;360(10):994-1001. doi: 10.1056/NEJMcp0806317.

Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?

J Endocrinol Invest. 2008 Jun;31(6):578-81. doi: 10.1007/BF03346411.